E-GEOD-38648 - Deactivation of Hepatic Stellate Cells during Liver Fibrosis Resolution in Mice
Released on 5 May 2014, last updated on 12 May 2014
Gene expression of mouse hepatic stellate cells was characterized under the following conditions: Quiescent (isolated from normal mouse liver) and reverted (isolated from mouse liver treated with 4 injections of carbontetrachloride followed by 45 day rest period) Affymetrix Mouse 1.0ST gene expression measurements were used to characterize the transcriptomic basis in quiescent hepatic stellate cells, isolated from normal liver, and reverted hepatic stellate cells, isolated from liver treated with 4 injections of CCl4 followed by a 45 day rest period. Gene expression of mouse hepatic stellate cells was characterized under the following conditions: A. Quiescent control hepatic stellate cells (n=4). B. Reverted hepatic stellate cells (n=4).
transcription profiling by array
Robert Schwabe <firstname.lastname@example.org>, Christine Hsu, Dianne H Dapito, Geum-Youn Gwak, Ingmar Mederacke, Jean-Philippe Pradere, Juliane S Troeger, Richard A Friedman, Robert F Schwabe, Xueru Mu
Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Troeger JS, Mederacke I, Gwak GY, Dapito DH, Mu X, Hsu CC, Pradere JP, Friedman RA, Schwabe RF. , Europe PMC 22750464